Growth Metrics

Lucid Diagnostics (LUCD) Income from Continuing Operations (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Income from Continuing Operations for 5 consecutive years, with 10397000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Income from Continuing Operations rose 15.96% year-over-year to 10397000.0, compared with a TTM value of 53285000.0 through Sep 2025, down 18.89%, and an annual FY2024 reading of 45529000.0, up 13.55% over the prior year.
  • Income from Continuing Operations was 10397000.0 for Q3 2025 at Lucid Diagnostics, down from 4439000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 3653000.0 in Q1 2021 and bottomed at 26908000.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 11799401.0, with a median of 11381000.0 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations crashed 235.89% in 2022, then surged 59.66% in 2025.
  • Year by year, Income from Continuing Operations stood at 11306000.0 in 2021, then tumbled by 32.04% to 14928000.0 in 2022, then increased by 27.45% to 10830000.0 in 2023, then dropped by 6.57% to 11541000.0 in 2024, then rose by 9.91% to 10397000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for LUCD at 10397000.0 in Q3 2025, 4439000.0 in Q2 2025, and 26908000.0 in Q1 2025.